PubMed Health⌕ Search

PubMed · 8092583

[Osmolality and brain].

Abstract

A modification of serum osmolarity induces always movements of water across cell membranes and therefore variations of cell volume of all tissues, including brain. To avoid a severe cell dehydration or hyperhydration, the organism has several regulation means called osmoregulation. Cerebral osmoregulation is essential as the brain is contained in a unexpandable box. In comparison with other organs, this phenomenon is complex and particular as: 1) cerebral volume consists of 3 sub spaces (intracellular, extracellular and cerebrospinal fluid [CSF]); 2) exists a blood-brain barrier (BBB) which behaves functionally as a semi-permeable membrane, essentially sensitive to osmolar disturbances. This brain volume regulation mechanism is working whatever the nature of the solutes initiating the osmotic deviation (sodium, glucose, mannitol...). Cerebral osmoregulation results from intracerebral osmolar modifications. Thus, every variation of plasma osmolarity elicits a similar variation of intracerebral osmolarity. This phenomenon results from modifications of the brain cell "protective" osmoles content. When the osmolar disturbance occurs quickly (in a few hours), cerebral osmoregulation is not complete. It results essentially from modifications of brain cell inorganic solutes content, i.e. electrolytes (Na, K, Cl) which originate from plasma, CSF and extracellular brain spaces uptake. When the osmolar disturbance is more progressive, cerebral osmoregulation is complete. The brain volume returns then to its initial value, by increasing its brain cell electrolytes, but above all organic "idiogenic" osmoles content. These idiogenic osmoles are identified as amino acids, polyols and trimethylamines. During treatment, the delayed normalization of brain osmolarity compared with plasma osmolarity prescribes a slow correction of the osmolar disturbance, as much as it is a chronic one.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Ichai, E Fenouil, D Grimaud. 1994. [Osmolality and brain].. https://doi.org/10.1016/s0750-7658(94)80189-4

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Protective effects of liver-derived apolipoprotein A1 against heat stress-induced hypothalamic lipid metabolism and blood-brain barrier integrity.

Heat stress (HS), a prevalent occupational and environmental hazard, has increasingly been recognized as a major contributor to multiple physiological disorders. The hypothalamus, a key regulator of thermoregulation and endocrine signaling, is especially susceptible to metabolic and inflammatory disturbances induced by HS. This study investigates the interplay among lipid metabolism, blood-brain barrier (BBB) integrity, and neuroinflammation in the hypothalamus under HS conditions, with a specific focus on apolipoprotein A1 (APOA1) as a potential protective factor. To achieve this, we integrated proteomic and lipidomic analyses with experimental validation in porcine and murine models. Proteomic analysis identified 266 differentially expressed proteins (DEPs) in the hypothalamus following HS, with significant enrichment in lipid metabolism pathways-especially glycerophospholipid (GP) metabolism-in which APOA1 displayed a marked increase. Lipidomic profiling further revealed HS-induced disruptions in phosphatidylcholine (PC), phosphatidylethanolamine (PE), and cardiolipin (CL) metabolism. Additionally, blood-brain barrier integrity was compromised, as evidenced by increased perivascular IgG extravasation, reduced pericyte coverage, and decreased expression of tight junction proteins ZO-1 and Occludin. HS also triggered pronounced neuroinflammation, characterized by elevated levels of iNOS, GFAP, and pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6). Notably, administration of D-4F, an APOA1 mimetic peptide, alleviated blood-brain barrier damage, reduced neuroinflammation, and preserved synaptic integrity, thereby suggesting a neuroprotective role for APOA1 in HS-induced hypothalamic dysfunction. These findings underscore the critical role of lipid metabolism in maintaining hypothalamic homeostasis under HS conditions and position APOA1 as a key regulator with potential therapeutic implications for mitigating HS-related neuroinflammatory and metabolic disturbances.

Blood-Brain Barrier↗

Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells.

Most cases of neonatal bacterial meningitis develop as a result of a hematogenous spread, but it is not clear how circulating bacteria cross the blood-brain barrier. Attempts to answer these questions have been hampered by the lack of a reliable model of the human blood-brain barrier. Human brain microvascular endothelial cells (HBMEC) were isolated and transfected with a pBR322 based plasmid containing simian virus 40 large T antigen (SV40-LT). The transfected HBMEC exhibited similar brain endothelial cell characteristics as the primary HBMEC, i.e. gamma glutamyl transpeptidase and a high transendothelial electrical resistance. Escherischia coli and Citrobacter spp, two important Gram-negative bacilli causing neonatal meningitis, were found to transcytose across primary and transfected HBMEC, without affecting the integrity of the monolayer. In addition, E. coli and C. freundii invaded transfected HBMEC as shown previously with primary HBMEC. We conclude that E. coli and C. freundii are able to invade and transcytose HBMEC and these bacterial-HBMEC interactions are similar between primary and transfected HBMEC. Therefore, our transfected HBMEC should be useful for studying pathogenesis of CNS infections.

Blood-Brain Barrier↗

Phosphatidylinositol 3-kinase activation and interaction with focal adhesion kinase in Escherichia coli K1 invasion of human brain microvascular endothelial cells.

Invasion of brain microvascular endothelial cells (BMEC) is a prerequisite for successful crossing of the blood-brain barrier by Escherichia coli K1. We have previously demonstrated the requirement of cytoskeletal rearrangements and activation of focal adhesion kinase (FAK) in E. coli K1 invasion of human BMEC (HBMEC). The current study investigated the role of phosphatidylinositol 3-kinase (PI3K) activation and PI3K interaction with FAK in E. coli invasion of HBMEC. PI3K inhibitor LY294002 blocked E. coli K1 invasion of HBMEC in a dose-dependent manner, whereas an inactive analogue LY303511 had no such effect. In HBMEC, E. coli K1 increased phosphorylation of Akt, a downstream effector of PI3K, which was completely blocked by LY294002. In contrast, non-invasive E. coli failed to activate PI3K. Overexpression of PI3K mutants Deltap85 and catalytically inactive p110 in HBMEC significantly inhibited both PI3K/Akt activation and E. coli K1 invasion of HBMEC. Stimulation of HBMEC with E. coli K1 increased PI3K association with FAK. Furthermore, PI3K/Akt activation was blocked in HBMEC-overexpressing FAK dominant-negative mutants (FRNK and Phe397FAK). These results demonstrated the involvement of PI3K signaling in E. coli K1 invasion of HBMEC and identified a novel role for PI3K interaction with FAK in the pathogenesis of E. coli meningitis.

Blood-Brain Barrier↗